Effects of selective sertonin reuptake inhibitors on subjective and objective sleep parameters in middle-aged women with depression

Effects of selective sertonin reuptake inhibitors on subjective and objective sleep parameters in middle-aged women with depression - Effects of selective sertonin reuptake inhibitors on subjective and objective sleep parameters in middle-aged women with depression

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009354

Enrollment

Registered

2012-11-19

Start date

2012-11-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

menopausal depression

Interventions

8-week treatment with 10 mg of escitalopram 8-week treatment with 12.5-25 mg of paroxetine CR

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: women with depressive symptoms

Exclusion criteria

Exclusion criteria: women who are treated with estrogens, Kampo medicine, psychotropic agents etc.

Design outcomes

Primary

Measure	Time frame
Athens Insomnia Scale Actigram	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026